<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99133">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01898858</url>
  </required_header>
  <id_info>
    <org_study_id>5546</org_study_id>
    <nct_id>NCT01898858</nct_id>
  </id_info>
  <brief_title>Effects of O2 and/or CO2 Inhalation on Rest and Exercise Pulmonary Hemodynamic</brief_title>
  <acronym>H2PAP</acronym>
  <official_title>Effects of O2 and/or CO2 Inhalation on Rest and Exercise Pulmonary Hemodynamic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: ANSM</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to describe the pulmonary hemodynamic evolution at rest and during
      a short constant load exercise in 4 conditions :

        -  normoxia

        -  hypoxia

        -  hypercapnia

        -  association hypoxia and hypercapnia
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Systolic Artery Pulmonary Pressure(sPAP) (echocardiography, Cardiac output (impedancemetry), Cardiorespiratory parameters</measure>
    <time_frame>at the end of the 30th minutes constant load exercise</time_frame>
    <safety_issue>No</safety_issue>
    <description>At rest and during exercise for each condition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnea and muscle leg discomfort using a Borg Scale</measure>
    <time_frame>at the end of the 30th minutes constant load exercise</time_frame>
    <safety_issue>No</safety_issue>
    <description>In each conditions at rest and during exercise</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Pulmonary Vascular Sensibility in Hypoxia</condition>
  <condition>Hypercapnia</condition>
  <condition>Hypoxia and Hypercapnia</condition>
  <arm_group>
    <arm_group_label>HYPOXIA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>HYPERCAPNIA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>HYPOXIA + HYPERCAPNIA</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypercapnia inhalation (Altitrainer NP 190)</intervention_name>
    <description>Hypercapnia inhalation using an Altitrainer NP 190</description>
    <arm_group_label>HYPERCAPNIA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypoxia and hypercapnia (Altitrainer NP 190)</intervention_name>
    <description>Hypoxia and hypercapnia inhalation using an Altitrainer NP 190</description>
    <arm_group_label>HYPOXIA + HYPERCAPNIA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypoxia inhalation (Altitrainer NP 190)</intervention_name>
    <description>Hypoxia inhalation using an Altitrainer NP 190</description>
    <arm_group_label>HYPOXIA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  healthy male

          -  exercise capacity between 100 and 130 % of theorical values

        Exclusion criteria:

          -  smoker

          -  headache

          -  impossibility to perform an exercise test

          -  no tricuspid regurgitation on the echocardiography
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PISTEA Cristina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PISTEA Cristina, MD</last_name>
    <phone>33.3.69.55.13.03</phone>
    <email>cristina.pistea@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DOUTRELEAU Stéphane, MD</last_name>
    <phone>33.3.69.55.13.03</phone>
    <email>stephane.doutreleau@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Physiologie et d'Explorations Fonctionnelles, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PISTEA Cristina, MD</last_name>
      <phone>33.3.69.55.13.03</phone>
      <email>cristina.pistea@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>DOUTRELEAU Stéphane, MD</last_name>
      <phone>33.3.69.55.13.03</phone>
      <email>stephane.doutreleau@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>PISTEA Cristina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>DOUTRELEAU Stéphane, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CHARLOUX Anne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>LONSDORFER Evelyne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DI MARCO Paola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>OSWALD Monique, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ENACHE Irina, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypercapnia</mesh_term>
    <mesh_term>Anoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
